Research Article

SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma

Figure 6

Comparison of immunological characteristics of different risk groups and differences of 22 immune cell scores (a), stromal, immune, and ESTIMATE scores (b) of the high- and low-risk groups in TCGA cohort. (c) Immune checkpoint genes differentially expressed in different risk groups in TCGA cohort. (d) The TIDE analysis results of different risk groups in TCGA cohort. , , , and .
(a)
(b)
(c)
(d)